Year: 2022

Cryptyde Completes Acquisition of Forever 8

Written by Customer Service on October 4, 2022. Posted in Public Companies.

The acquisition provides the opportunity to capture sustainable market share within the multi-billion-dollar fintech sector SAFETY HARBOR, Florida, Oct. 04, 2022 (GLOBE NEWSWIRE) — Cryptyde, Inc. (NASDAQ: TYDE) today announced that it has successfully closed the acquisition of Forever 8 Fund, LLC, an e-commerce fintech company (“Forever 8”). The acquisition lays the foundation for Cryptyde’s fintech portfolio and positions Cryptyde to generate revenue from the F8 acquisition, beginning in Q4 of 2022 “We are pleased to have closed this pivotal acquisition of Forever 8, which will not only add revenue, it also positions Cryptyde as a future leader in the financial technology space,” said Brian McFadden, CEO of Cryptyde. “We believe we have a unique offering within the fintech universe, with Forever 8 providing an opportunity to combine...

Enovix Celebrates Fremont Manufacturing Week & U.S. Manufacturing Day

Written by Customer Service on October 4, 2022. Posted in Public Companies.

Enovix Manufacturing Line Enovix next-gen batteries on the manufacturing line at its headquarters in Fremont, CaliforniaFREMONT, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX) the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced the company is celebrating Fremont Manufacturing Week and U.S. Manufacturing Day, hosting multiple student tours with the City of Fremont and actively hiring positions throughout the company. “We’re thrilled to open our doors to local students who are interested in learning more about U.S. innovation and manufacturing,” said Harrold Rust, Co-founder, President and Chief Executive Officer of Enovix. “While we still have to rely on global supply chains for some of our inputs, Enovix is one of the few companies...

Stellantis to Announce Third Quarter 2022, Shipments and Revenues on November 3

Written by Customer Service on October 4, 2022. Posted in Earnings Releases And Operating Results.

Stellantis to Announce Third Quarter 2022Shipments and Revenues on November 3 AMSTERDAM, October 4, 2022 – Stellantis N.V. announced today that its Third Quarter 2022 Shipments and Revenues will be released on Thursday, November 3, 2022. A live audio webcast and conference call of the Q3 2022 Shipments and Revenues will begin at 1:00 p.m. CET / 8:00 a.m. EDT on Thursday, November 3, 2022. The related press release and presentation material are expected to be posted under the Investors section of the Stellantis corporate website at www.stellantis.com at approximately 8:00 a.m. CET / 3:00 a.m. EDT on Thursday, November 3, 2022. Details for accessing this presentation are available under the Investors section of the Stellantis corporate website at www.stellantis.com. For those unable to participate in the live session, a recorded replay will...

PyroGenesis Confirms Additional $682,000 Payment Under $25M+ DROSRITE™ Contract

Written by Customer Service on October 4, 2022. Posted in Public Companies.

MONTREAL, Oct. 04, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes, high quality plasma atomized metal powder for 3D printing and additive manufacturing, and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to confirm today that, in response to additional inquiries with respect to the subject matter, the Company has received a payment of approx. $682,000 under the exclusivity contract with Drosrite International LLC (“DI”). In addition to the payment received today, PyroGenesis expects to receive further payments, the timing of which has been scheduled to match the end user’s...

atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

Written by Customer Service on October 4, 2022. Posted in Public Companies.

NEW YORK and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in in the following investor events & host a virtual R&D Day in October:Roth Inaugural Healthcare Opportunities Conference in New York CityFormat: Company presentationDate and Time: Thursday, October 6th, 11:45 a.m. ET – 12:15 p.m. ETConference link: Roth Inaugural Healthcare Opportunities ConferenceCantor Fitzgerald’s Neurology & Psychiatry Conference in San FranciscoFormat: Industry panelsDate and Time: Thursday, October 6th, 2:10 p.m. ET – 3:10 p.m. ET & Friday, October 7th, 11:00 a.m. – 12:00 p.m. ETConference link: Cantor Fitzgerald’s Neurology & Psychiatry Conferenceatai...

OneWater Marine Inc. Completes the Acquisition of Taylor Marine Centers

Written by Customer Service on October 4, 2022. Posted in Mergers And Acquisitions.

Acquisition strengthens geographic positioning in the Mid-Atlantic U.S. BUFORD, Ga., Oct. 04, 2022 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or “the Company”) announced today that it has completed the previously announced acquisition of Taylor Marine Centers. The transaction expands the Company’s presence in the Mid-Atlantic U.S. and enhances new and pre-owned boat sales, finance, and parts and services offerings. “The acquisition of Taylor Marine Centers is another great addition to our impressive list of strategic acquisitions. This transaction complements our recent acquisition of Norfolk Marine Inc., further emphasizing our commitment to expand our geographic reach in attractive marine markets,” said Austin Singleton, Chief Executive Officer for OneWater. About OneWater Marine Inc. OneWater Marine...

Irwin Naturals Agrees to Add Idaho Clinic to Its National Chain of Psychedelic Mental-Health Clinics

Written by Customer Service on October 4, 2022. Posted in Mergers And Acquisitions.

Irwin Naturals Emergence announces acquisition agreement in Idaho, continuing national rollup of ketamine clinics LOS ANGELES, Oct. 04, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement on September 30, 2022 to acquire Ketamine Infusions of Idaho, PLLC, which operates a clinic in Idaho Falls. The clinic will join Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics, which already has deals to add a total of 11 clinics across six different states. This clinic will be the chain’s first in Idaho. Klee Irwin, CEO of Irwin Naturals said, “We are so impressed by the care and expertise that Christina Stubbs and her team provide, and we are truly excited to welcome this clinic into our rapidly expanding family....

Form 8.3 – [GB Group plc – 03 10 2022] – (CGWL)

Written by Customer Service on October 4, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GB GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Plus Therapeutics to Share Data in Oral Presentations from Ongoing ReSPECT™ Clinical Trials at the 35th Annual Congress of the European Association of Nuclear Medicine

Written by Customer Service on October 4, 2022. Posted in Public Companies.

Leptomeningeal metastases data has been selected as a “Top Rated Oral Presentation” by EANM AUSTIN, Texas, Oct. 04, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will present data from two ongoing clinical trials evaluating the Company’s lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome (186RNL), in recurrent glioblastoma and leptomeningeal metastases at the 35th Annual Congress of the European Association of Nuclear Medicine (EANM), being held October 15-19, 2022 in Barcelona, Spain. Details of oral presentation:Title OP-542: Safety and Feasibility of Rhenium-186 NanoLiposome (186RNL) in Recurrent Glioma: the ReSPECT™ Phase...

Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform

Written by Customer Service on October 4, 2022. Posted in Public Companies.

– Favorable Safety Profiles and Encouraging Efficacy Data Reported in Clinical Trials in the Suprachoroidal Space (SCS®) Across Multiple Therapeutic Areas using Clearside’s SCS Microinjector® – – SCS Microinjector® Featured in Multiple Oral and Poster Presentations at Recent American Academy of Ophthalmology (AAO) 2022 Annual Meeting – ALPHARETTA, Ga., Oct. 04, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that clinical data from multiple internal and partnered programs were presented at the recent 2022 Annual Meeting of the American Academy of Ophthalmology (AAO), the world’s largest association of eye physicians and surgeons. “These...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals